110 related articles for article (PubMed ID: 36306198)
1. PICT-1 regulates p53 splicing and sensitivity of medullary thyroid carcinoma cells to everolimus.
Bareli Y; Shimon I; Tobar A; Rubinfeld H
J Neuroendocrinol; 2022 Oct; 34(10):e13187. PubMed ID: 36306198
[TBL] [Abstract][Full Text] [Related]
2. PICT-1 triggers a pro-death autophagy through inhibiting rRNA transcription and AKT/mTOR/p70S6K signaling pathway.
Chen H; Duo Y; Hu B; Wang Z; Zhang F; Tsai H; Zhang J; Zhou L; Wang L; Wang X; Huang L
Oncotarget; 2016 Nov; 7(48):78747-78763. PubMed ID: 27729611
[TBL] [Abstract][Full Text] [Related]
3. The protein interacting with carboxyl terminus-1 codon 389 polymorphism impairs protein interacting with carboxyl terminus-1 function and is a risk factor for uterine cervical cancer.
Yoshimoto M; Tokuda A; Nishiwaki K; Sengoku K; Yaginuma Y
Mol Carcinog; 2017 May; 56(5):1484-1492. PubMed ID: 27996172
[TBL] [Abstract][Full Text] [Related]
4. PICT-1 is a key nucleolar sensor in DNA damage response signaling that regulates apoptosis through the RPL11-MDM2-p53 pathway.
Chen H; Han L; Tsai H; Wang Z; Wu Y; Duo Y; Cao W; Chen L; Tan Z; Xu N; Huang X; Zhuang J; Huang L
Oncotarget; 2016 Dec; 7(50):83241-83257. PubMed ID: 27829214
[TBL] [Abstract][Full Text] [Related]
5. Nucleolar localization of GLTSCR2/PICT-1 is mediated by multiple unique nucleolar localization sequences.
Kalt I; Levy A; Borodianskiy-Shteinberg T; Sarid R
PLoS One; 2012; 7(1):e30825. PubMed ID: 22292050
[TBL] [Abstract][Full Text] [Related]
6. The nucleolar PICT-1/GLTSCR2 protein forms homo-oligomers.
Borodianskiy-Shteinberg T; Kalt I; Kipper S; Nachum N; Katz S; Pauker MH; Barda-Saad M; Gerber D; Sarid R
J Mol Biol; 2014 Jun; 426(12):2363-78. PubMed ID: 24735870
[TBL] [Abstract][Full Text] [Related]
7. Synergistic Antitumor Effect of BKM120 with Prima-1Met Via Inhibiting PI3K/AKT/mTOR and CPSF4/hTERT Signaling and Reactivating Mutant P53.
Li Z; Xu X; Li Y; Zou K; Zhang Z; Xu X; Liao Y; Zhao X; Jiang W; Yu W; Guo W; Chen Y; Li Y; Chen M; Deng WG; Li L; Zou L
Cell Physiol Biochem; 2018; 45(5):1772-1786. PubMed ID: 29495002
[TBL] [Abstract][Full Text] [Related]
8. GLTSCR2/PICT-1, a putative tumor suppressor gene product, induces the nucleolar targeting of the Kaposi's sarcoma-associated herpesvirus KS-Bcl-2 protein.
Kalt I; Borodianskiy-Shteinberg T; Schachor A; Sarid R
J Virol; 2010 Mar; 84(6):2935-45. PubMed ID: 20042497
[TBL] [Abstract][Full Text] [Related]
9. The HDM2 (MDM2) Inhibitor NVP-CGM097 Inhibits Tumor Cell Proliferation and Shows Additive Effects with 5-Fluorouracil on the p53-p21-Rb-E2F1 Cascade in the p53wild type Neuroendocrine Tumor Cell Line GOT1.
Reuther C; Heinzle V; Nölting S; Herterich S; Hahner S; Halilovic E; Jeay S; Wuerthner JU; Aristizabal Prada ET; Spöttl G; Maurer J; Auernhammer CJ
Neuroendocrinology; 2018; 106(1):1-19. PubMed ID: 27871087
[TBL] [Abstract][Full Text] [Related]
10. K-Ras mutation and amplification status is predictive of resistance and high basal pAKT is predictive of sensitivity to everolimus in biliary tract cancer cell lines.
Yeung Y; Lau DK; Chionh F; Tran H; Tse JWT; Weickhardt AJ; Nikfarjam M; Scott AM; Tebbutt NC; Mariadason JM
Mol Oncol; 2017 Sep; 11(9):1130-1142. PubMed ID: 28544747
[TBL] [Abstract][Full Text] [Related]
11. p53 suppresses carcinoma progression by inhibiting mTOR pathway activation.
Akeno N; Miller AL; Ma X; Wikenheiser-Brokamp KA
Oncogene; 2015 Jan; 34(5):589-99. PubMed ID: 24469052
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of mTOR's Catalytic Site by PKI-587 Is a Promising Therapeutic Option for Gastroenteropancreatic Neuroendocrine Tumor Disease.
Freitag H; Christen F; Lewens F; Grass I; Briest F; Iwaszkiewicz S; Siegmund B; Grabowski P
Neuroendocrinology; 2017; 105(1):90-104. PubMed ID: 27513674
[TBL] [Abstract][Full Text] [Related]
13. Next-generation sequencing reveals somatic mutations that confer exceptional response to everolimus.
Lim SM; Park HS; Kim S; Kim S; Ali SM; Greenbowe JR; Yang IS; Kwon NJ; Lee JL; Ryu MH; Ahn JH; Lee J; Lee MG; Kim HS; Kim H; Kim HR; Moon YW; Chung HC; Kim JH; Kang YK; Cho BC
Oncotarget; 2016 Mar; 7(9):10547-56. PubMed ID: 26859683
[TBL] [Abstract][Full Text] [Related]
14. Sorafenib and Mek inhibition is synergistic in medullary thyroid carcinoma in vitro.
Koh YW; Shah MH; Agarwal K; McCarty SK; Koo BS; Brendel VJ; Wang C; Porter K; Jarjoura D; Saji M; Ringel MD
Endocr Relat Cancer; 2012 Feb; 19(1):29-38. PubMed ID: 22109971
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of preclinical efficacy of everolimus and pasireotide in thyroid cancer cell lines and xenograft models.
Owonikoko TK; Zhang G; Lallani SB; Chen Z; Martinson DE; Khuri FR; Lonial S; Marcus A; Sun SY
PLoS One; 2019; 14(2):e0206309. PubMed ID: 30807575
[TBL] [Abstract][Full Text] [Related]
16. Long-term acquired everolimus resistance in pancreatic neuroendocrine tumours can be overcome with novel PI3K-AKT-mTOR inhibitors.
Vandamme T; Beyens M; de Beeck KO; Dogan F; van Koetsveld PM; Pauwels P; Mortier G; Vangestel C; de Herder W; Van Camp G; Peeters M; Hofland LJ
Br J Cancer; 2016 Mar; 114(6):650-8. PubMed ID: 26978006
[TBL] [Abstract][Full Text] [Related]
17. Moesin-ezrin-radixin-like protein (merlin) mediates protein interacting with the carboxyl terminus-1 (PICT-1)-induced growth inhibition of glioblastoma cells in the nucleus.
Chen H; Mei L; Zhou L; Zhang X; Guo C; Li J; Wang H; Zhu Y; Zheng Y; Huang L
Int J Biochem Cell Biol; 2011 Apr; 43(4):545-55. PubMed ID: 21167305
[TBL] [Abstract][Full Text] [Related]
18. Regulation of PTEN phosphorylation and stability by a tumor suppressor candidate protein.
Okahara F; Ikawa H; Kanaho Y; Maehama T
J Biol Chem; 2004 Oct; 279(44):45300-3. PubMed ID: 15355975
[TBL] [Abstract][Full Text] [Related]
19. Chromogranin A and its fragments as regulators of small intestinal neuroendocrine neoplasm proliferation.
Giovinazzo F; Schimmack S; Svejda B; Alaimo D; Pfragner R; Modlin I; Kidd M
PLoS One; 2013; 8(11):e81111. PubMed ID: 24260544
[TBL] [Abstract][Full Text] [Related]
20. Critical role of PICT-1, a tumor suppressor candidate, in phosphatidylinositol 3,4,5-trisphosphate signals and tumorigenic transformation.
Okahara F; Itoh K; Nakagawara A; Murakami M; Kanaho Y; Maehama T
Mol Biol Cell; 2006 Nov; 17(11):4888-95. PubMed ID: 16971513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
